FrancophonIA/ELRC3.0 huggingface dataset:
English: Copalia HCT should be used with caution to treat hypertension in patients with unilateral or bilateral renal artery stenosis or stenosis to a solitary kidney since blood urea and serum creatinine may increase in such patients.
Croatian: Copalia HCT se treba primjenjivati s oprezom u liječenju hipertenzije u bolesnika s jednostranom ili obostranom stenozom bubrežne arterije ili stenozom bubrežne arterije kod postojanja samo jednog bubrega budući da se u ovih bolesnika može povisiti urea u krvi i serumski kreatinin.
English: The amlodipine component of Copalia HCT inhibits the transmembrane entry of calcium ions into cardiac and vascular smooth muscle.
Croatian: Amlodipinska komponenta Copalia HCT-a inhibira transmembranski ulaz iona kalcija u srčani mišić i glatki mišić krvnih žila.
English: Based on the existing data with the components, the use of Copalia HCT is not recommended during first trimester and contraindicated during the second and third trimester of pregnancy (see sections 4.3 and 4.4).
Croatian: Na temelju postojećih podataka o komponentama, primjena Copalia HCT-a ne preporučuje se tijekom prvog tromjesečja, dok je tijekom drugog i trećeg tromjesečja trudnoće kontraindicirana (vidjeti dijelove 4.3 i 4.4).
English: Copalia HCT combines three antihypertensive compounds with complementary mechanisms to control blood pressure in patients with essential hypertension: amlodipine belongs to the calcium antagonist class and valsartan to the angiotensin II antagonist class of medicines and hydrochlorothiazide belongs to the thiazide diuretics class of medicines.
Croatian: Copalia HCT kombinira tri antihipertenzivna sastojka s komplementarnim mehanizmima kontrole krvnog tlaka u bolesnika s esencijalnom hipertenzijom: amlodipin pripada skupini kalcijevih antagonista, valsartan pripada skupini antagonista angiotenzina II, a hidroklorotiazid pripada skupini tiazidnih diuretika.
English: In this active controlled clinical trial, the most common reasons for discontinuation of therapy with Copalia HCT were dizziness and hypotension (0.7%).
Croatian: Najčešći razlozi prekida terapije Copalia HCT-om u ovom aktivno kontroliranom kliničkom ispitivanju bili su omaglica i hipotenzija (0,7%).
English: Furthermore, concomitant use of Copalia HCT and NSAIDs may lead to worsening of renal function and an increase in serum potassium.
Croatian: Osim toga, istodobna primjena Copalia HCT-a i NSAIL-a može dovesti do pogoršanja bubrežne funkcije i povećanja kalija u serumu.
English: In the controlled trial of Copalia HCT, the counteracting effects of valsartan 320 mg and hydrochlorothiazide 25 mg on serum potassium approximately balanced each other in many patients.
Croatian: U kontroliranom ispitivanju Copalia HCT-a, suprotni učinci 320 mg valsartana i 25 mg hidroklorotiazida na kalij u serumu su se približno uravnotežili u mnogih bolesnika.
English: Other medicines and Copalia HCT
Croatian: Drugi lijekovi i Copalia HCT
English: Copalia HCT is used to treat high blood pressure in adult patients whose blood pressure is already controlled while taking amlodipine, valsartan and hydrochlorothiazide and who may benefit from taking one tablet containing all three substances.
Croatian: Copalia HCT se primjenjuje za liječenje povišenog krvnog tlaka u odraslih bolesnika čiji je krvni tlak već kontroliran dok uzimaju amlodipin, valsartan i hidroklorotiazid te kojima uzimanje jedne tablete koja sadrži sve tri djelatne tvari može biti od koristi.
English: In sodium-depleted and/or volume-depleted patients, such as those receiving high doses of diuretics, symptomatic hypotension may occur after initiation of treatment with Copalia HCT.
Croatian: U bolesnika sa sniženom razinom natrija i/ili smanjenjem volumena tekućine, poput onih koji primaju visoke doze diuretika, nakon početka liječenja Copalia HCT-om moguća je pojava simptomatske hipotenzije.
English: When Copalia HCT is used in patients with renal impairment periodic monitoring of serum electrolytes (including potassium), creatinine and uric acid serum levels is recommended.
Croatian: Kada se Copalia HCT primjenjuje u bolesnika s oštećenjem bubrega preporučuje se periodičko praćenje serumskih elektrolita (uključujući kalij), razina kreatinina i mokraćne kiseline u serumu.
English: if you have or have had heart failure or coronary artery disease, particularly if you are prescribed the maximum dose of Copalia HCT (10 mg/320 mg/25 mg).
Croatian: ako imate ili ste imali zatajenje srca ili bolest koronarnih arterija, posebno ako je propisano da uzimate najvišu dozu Copalia HCT-a (10 mg/320 mg/25 mg).
English: If excessive hypotension occurs with Copalia HCT, the patient should be placed in the supine position and, if necessary, given an intravenous infusion of normal saline.
Croatian: Ako se uz Copalia HCT pojavi izrazita hipotenzija, bolesnika treba poleći na leđa i po potrebi, mu dati intravensku infuziju fiziološke otopine.
English: If you get these symptoms, stop taking Copalia HCT and contact your doctor straight away.
Croatian: Ako dobijete ove simptome, prekinite uzimati Copalia HCT i odmah se javite svom liječniku.
English: The safety profile of Copalia HCT presented below is based on clinical studies performed with Copalia HCT and the known safety profile of the individual components amlodipine, valsartan and hydrochlorothiazide.
Croatian: Niže prikazani sigurnosni profil Copalia HCT-a temelji se na kliničkim ispitivanjima Copalia HCT-a i poznatom sigurnosnom profilu pojedinačnih komponenti amlodipina, valsartana i hidroklorotiazida.
English: In case severe or rapid hyponatraemia develops during Copalia HCT therapy, the treatment should be discontinued until normalisation of natraemia.
Croatian: U slučaju razvoja teškog ili brzog oblika hiponatrijemije tijekom terapije Copalia HCT-om, liječenje je potrebno prekinuti do normalizacije natrijemije.
English: There is no experience on the use of Copalia HCT in pregnant women.
Croatian: Nema iskustva s primjenom Copalia HCT-a u trudnica.
English: The following adverse reactions, listed by MedDRA System Organ Class and frequency, concern Copalia HCT (amlodipine/valsartan/HCT) and amlodipine, valsartan and HCT individually.
Croatian: Sljedeće nuspojave, navedene prema MedDRA-inoj klasifikaciji organskih sustava i učestalosti, odnose se na Copalia HCT (amlodipin/valsartan/HCT) i amlodipin, valsartan i HCT pojedinačno.
English: In the 8-week controlled clinical study, changes in laboratory parameters observed with the combination of Copalia HCT were minor and consistent with the pharmacological mechanism of action of the monotherapy agents.
Croatian: Promjene vrijednosti laboratorijskih parametera opažene s kombinacijom Copalia HCT tijekom 8tjednog kontroliranog kliničkog ispitivanja bile su manje i u skladu s farmakološkim mehanizmom djelovanja pojedinačnih komponenti.
English: What Copalia HCT contains
Croatian: Što Copalia HCT sadrži
English: The use of Copalia HCT during breastfeeding is not recommended.
Croatian: Primjena Copalia HCT-a tijekom dojenja se ne preporučuje.
English: The side effects reported with Copalia HCT or one of its three active substances (amlodipine, valsartan and hydrochlorothiazide) are listed below and may occur with the use of Copalia HCT.
Croatian: Nuspojave prijavljene za Copalia HCT ili za jednu od tri komponente (amlodipin, valsartan i hidroklorotiazid) navedene su niže i mogu se javiti kod uzimanja Copalia HCT.
English: Copalia HCT tablets contain three substances called amlodipine, valsartan and hydrochlorothiazide.
Croatian: Copalia HCT tablete sadrže tri djelatne tvari koje se zovu amlodipin, valsartan i hidroklorotiazid.
English: The safety of Copalia HCT has been evaluated at its maximum dose of 10 mg/320 mg/25 mg in one controlled short-term (8 weeks) clinical study with 2,271 patients, 582 of whom received valsartan in combination with amlodipine and hydrochlorothiazide.
Croatian: Sigurnost primjene Copalia HCT-a je ispitivana u njegovoj najvišoj dozi od 10 mg/320 mg/25 mg u jednom kontroliranom kratkotrajnom (8 tjedana) kliničkom ispitivanju s 2271 bolesnikom, od kojih je 582 primalo valsartan u kombinaciji s amlodipinom i hidroklorotiazidom.
English: When switching eligible elderly hypertensive patients (see section 4.1) to Copalia HCT, the lowest available dose of the amlodipine component should be used.
Croatian: Prilikom prebacivanja starijih hipertenzivnih bolesnika koji ispunjavaju uvjete za liječenje (vidjeti dio 4.1) na Copalia HCT, treba se koristiti najniža dostupna doza amlodipina kao komponente.
English: Due to the hydrochlorothiazide component, Copalia HCT is contraindicated for use in patients with anuria (see section 4.3) and in patients with severe renal impairment (glomerular filtration rate (GFR) <30 ml/min/1.73 m2) (see sections 4.3, 4.4 and 5.2).
Croatian: Zbog hidroklorotiazidne komponente, primjena Copalia HCT je kontraindicirana u bolesnika s anurijom (vidjeti dio 4.3) i u bolesnika s teškim oštećenjem bubrega (brzina glomerularne filtracije (GFR) <30 ml/min/1,73 m2) (vidjeti dijelove 4.3, 4.4 i 5.2).
English: Copalia HCT is contraindicated in patients with hypercalcaemia and should only be used after correction of any pre-existing hypercalcaemia.
Croatian: Copalia HCT je kontraindicirana u bolesnika s hiperkalcijemijom te se smije primjenjivati tek nakon korekcije eventualne, već postojeće hiperkalcijemije.
English: Following oral administration of Copalia HCT in normal healthy adults, peak plasma concentrations of amlodipine, valsartan and hydrochlorothiazide are reached in 6-8 hours, 3 hours, and 2 hours, respectively.
Croatian: Nakon peroralne primjene Copalia HCT-a u normalnih, zdravih odraslih osoba, vršne koncentracije amlodipina u plazmi postižu se za 6-8 sati, valsartana unutar 3 sata, a hidroklorotiazida unutar 2 sata.
English: If photosensitivity reaction occurs during treatment with Copalia HCT, it is recommended to stop the treatment.
Croatian: Ako se tijekom liječenja Copalia HCT-om javi fotosenzitivna reakcija, preporučuje se prekinuti liječenje.
English: No formal interaction studies with other medicinal products have been performed with Copalia HCT.
Croatian: Nisu provedena formalna ispitivanja interakcija Copalia HCT-a s drugim lijekovima.
English: When switching eligible hypertensive patients (see section 4.1) with hepatic impairment to Copalia HCT, the lowest available dose of the amlodipine component should be used.
Croatian: Prilikom prebacivanja hipertenzivnih bolesnika koji ispunjavaju uvjete za liječenje (vidjeti dio 4.1) s oštećenjem jetre na Copalia HCT, treba se koristiti najniža dostupna doza amlodipina kao komponente.
English: If any of the above applies to you, do not take Copalia HCT and talk to your doctor.
Croatian: Ako se bilo što od navedenog odnosi na Vas, nemojte uzeti Copalia HCT i obavijestite svog liječnika.
English: The maximum recommended dose of Copalia HCT is 10 mg/320 mg/25 mg.
Croatian: Najviša preporučena doza Copalia HCT-a je 10 mg/320 mg/25 mg.
English: Do not use any Copalia HCT pack that is damaged or shows signs of tampering.
Croatian: Copalia HCT se ne smije upotrijebiti ukoliko primjetite da je pakiranje oštećeno ili su vidljivi znakovi otvaranja.
English: If you stop taking Copalia HCT
Croatian: Ako prestanete uzimati Copalia HCT
English: There is no experience of overdose with Copalia HCT.
Croatian: Nema iskustva s predoziranjem Copalia HCT-om.
English: In patients with mild to moderate hepatic impairment without cholestasis, the maximum recommended dose is 80 mg valsartan, and therefore, Copalia HCT is not suitable in this group of patients (see sections 4.2, 4.3 and 5.2).
Croatian: U bolesnika s blagim do umjerenim oštećenjem jetre, bez kolestaze, najviša preporučena doza valsartana je 80 mg, stoga Copalia HCT nije prikladna u toj skupini bolesnika (vidjeti dijelove 4.2, 4.3 i 5.2).
English: Caution is advised in patients with heart failure and coronary artery disease, particularly at the maximum dose of Copalia HCT, 10 mg/320 mg/25 mg, since available data in these patient populations is limited.
Croatian: Savjetuje se oprez u bolesnika sa zatajivanjem srca i bolešću koronarnih arterija, osobito pri najvišoj dozi Copalia HCT-a, 10 mg/320 mg/25 mg, jer su dostupni podaci u ovoj populaciji bolesnika ograničeni.
English: Concomitant use of Copalia HCT with aliskiren-containing products in patients with diabetes mellitus or renal impairment (GFR <60 ml/min/1.73 m2) (see sections 4.5 and 5.1).
Croatian: Istodobna primjena Copalia HCT s lijekovima koji sadrže aliskiren kontraindicirana je u bolesnika sa šećernom bolešću ili oštećenjem bubrega (GFR <60 ml/min/1,73 m2) (vidjeti dijelove 4.5 i 5.1).
English: Copalia HCT is contraindicated in patients with severe renal impairment, anuria or undergoing dialysis (see section 4.3).
Croatian: Copalia HCT je kontraindicirana u bolesnika s teškim oštećenjem bubrega, anurijom ili u bolesnika na dijalizi (vidjeti dio 4.3).
English: Due to the valsartan component, Copalia HCT is contraindicated in patients with severe hepatic impairment (see section 4.3).
Croatian: Zbog komponente valsartana, Copalia HCT je kontraindicirana u bolesnika s teškim oštećenjem jetre (vidjeti dio 4.3).
English: This is because grapefruit and grapefruit juice can lead to an increase in the blood levels of the active substance amlodipine, which can cause an unpredictable increase in the blood pressure lowering effect of Copalia HCT.
Croatian: Grejp i sok od grejpa u nekih bolesnika može dovesti do povećanja razina djelatne tvari amlodipina u krvi, što može uzrokovati neočekivano pojačani učinak Copalia HCT-a na snižavanje krvnog tlaka.
English: At week 8, the mean reductions in systolic/diastolic blood pressure were 39.7/24.7 mmHg with Copalia HCT, 32.0/19.7 mmHg with valsartan/hydrochlorothiazide, 33.5/21.5 mmHg with amlodipine/valsartan, and 31.5/19.5 mmHg with amlodipine/hydrochlorothiazide.
Croatian: U 8. tjednu, srednja vrijednost sniženja sistoličkog/dijastoličkog krvnog tlaka bila je 39,7/24,7 mmHg s Copalia HCT-om, 32,0/19,7 mmHg s valsartanom/hidroklorotiazidom, 33,5/21,5 mmHg s amlodipinom/valsartanom te 31,5/19,5 mmHg s amlodipinom/hidroklorotiazidom.
English: If you forget to take Copalia HCT
Croatian: Ako ste zaboravili uzeti Copalia HCT
English: The reductions in systolic/diastolic blood pressure with Copalia HCT were 7.6/5.0 mmHg greater than with valsartan/hydrochlorothiazide, 6.2/3.3 mmHg greater than with amlodipine/valsartan, and 8.2/5.3 mmHg greater than with amlodipine/hydrochlorothiazide.
Croatian: Sniženje sistoličkog/dijastoličkog krvnog tlaka postignuto Copalia HCT-om bilo je 7,6/5,0 mmHg veće nego s valsartanom/hidroklorotiazidom, za 6,2/3,3 mmHg veće od onog s amlodipinom/valsartanom te za 8,2/5,3 mmHg veće od onog s amlodipinom/hidroklorotiazidom.
English: Copalia HCT should be used only after correction of any pre-existing sodium and/or volume depletion.
Croatian: Copalia HCT smije se primjenjivati tek nakon korigiranja snižene razine natrija i/ili volumena tekućine.
English: Treatment with Copalia HCT should only start after correction of hypokalaemia and any coexisting hypomagnesaemia.
Croatian: Liječenje Copalia HCT-om smije se započeti tek nakon korigiranja hipokalijemije i eventualne prateće hipomagnezijemije.
English: In patients with mild to moderate hepatic impairment without cholestasis, the maximum recommended dose is 80 mg valsartan and therefore Copalia HCT is not suitable in this group of patients (see sections 4.3, 4.4 and 5.2).
Croatian: U bolesnika s blagim do umjerenim oštećenjem jetre, bez kolestaze, najviša preporučena doza valsartana je 80 mg te Copalia HCT stoga nije pogodna za ovu skupinu bolesnika (vidjeti dijelove 4.3, 4.4 i 5.2).
English: Due to the valsartan component, Copalia HCT is contraindicated in patients with hepatic impairment (see sections 4.2 and 4.3).
Croatian: Zbog valsartanske komponente Copalia HCT je kontraindicirana u bolesnika s oštećenjem jetre (vidjeti djelove 4.2 i 4.3).
English: There are no clinical studies on fertility with Copalia HCT.
Croatian: Ne postoje klinička ispitivanja djelovanja Copalia HCT-a na plodnost.
English: Amlodipine/Valsartan/Hydrochlorothiazide
Croatian: Amlodipin/valsartan/hidroklorotiazid
English: Amlodipine/valsartan/hydrochlorothiazide
Croatian: Amlodipin/Valsartan/Hidroklorotiazid
English: Caution is advised in patients with heart failure and coronary artery disease, particularly at the maximum dose of Copalia HCT, 10 mg/320 mg/25 mg.
Croatian: Savjetuje se oprez u bolesnika sa zatajenjem srca i bolešću koronarnih arterija, posebno u najvišoj dozi Copalia HCT-a, 10 mg/320 mg/25 mg.
English: Copalia HCT 5 mg/160 mg/12.5 mg film-coated tablets Copalia HCT 10 mg/160 mg/12.5 mg film-coated tablets Copalia HCT 5 mg/160 mg/25 mg film-coated tablets Copalia HCT 10 mg/160 mg/25 mg film-coated tablets Copalia HCT 10 mg/320 mg/25 mg film-coated tablets
Croatian: Copalia HCT 5 mg/160 mg/12,5 mg filmom obložene tablete Copalia HCT 10 mg/160 mg/12,5 mg filmom obložene tablete Copalia HCT 5 mg/160 mg/25 mg filmom obložene tablete Copalia HCT 10 mg/160 mg/25 mg filmom obložene tablete Copalia HCT 10 mg/320 mg/25 mg filmom obložene tablete
English: Copalia HCT individual component
Croatian: Pojedinačna komponenta Copalia HCT-a
English: Copalia HCT should be discontinued immediately in patients who develop angioedema and should not be re-administered.
Croatian: Bolesnici u kojih se razvije angioedem trebaju odmah prekinuti primjenu Copalia HCT-a i više je ne smiju ponovo uzimati.
English: How to take Copalia HCT
Croatian: Kako uzimati Copalia HCT
English: If you take more Copalia HCT than you should If you have accidentally taken too many Copalia HCT tablets, talk to a doctor immediately.You may require medical attention.
Croatian: Ako ste slučajno uzeli previše tableta Copalia HCT-a, odmah se obratite liječniku.
English: This is a disease in which the adrenal glands make too much of the hormone aldosterone If this applies to you, the use of Copalia HCT is not recommended.
Croatian: To je bolest kod koje nadbubrežne žlijezde stvaraju previše hormona aldosterona.
English: Hypromellose, substitution type 2910 (3 mPa.s) Titanium dioxide (E171) Macrogol 4000
Croatian: Hipromeloza zamjenski tip 2910 (3 mPas) titanijev dioksid (E171) makrogol 4000 talk
English: Excessive hypotension, including orthostatic hypotension, was seen in 1.7% of patients treated with the maximum dose of Copalia HCT (10 mg/320 mg/25 mg) compared to 1.8% of valsartan/hydrochlorothiazide (320 mg/25 mg) patients, 0.4% of amlodipine/valsartan (10 mg/320 mg) patients, and 0.2% of hydrochlorothiazide/amlodipine (25 mg/10 mg) patients in a controlled trial in patients with moderate to severe uncomplicated hypertension.
Croatian: U kontroliranom ispitivanju provedenom u bolesnika s umjerenom do teškom nekompliciranom hipertenzijom, izrazita hipotenzija, uključujući ortostatsku hipotenziju, viđena je u 1,7% bolesnika liječenih najvišom dozom Copalia HCT-a (10 mg/320 mg/25 mg) u usporedbi s 1,8% bolesnika liječenih valsartanom/hidroklorotiazidom (320 mg/25 mg), 0,4% bolesnika liječenih amlodipinom/valsartanom (10 mg/320 mg) i 0,2% bolesnika liječenih hidroklorotiazidom/amlodipinom (25 mg/10 mg).
English: Copalia HCT 5 mg/160 mg/12.5 mg film-coated tablets Copalia HCT 10 mg/160 mg/12.5 mg film-coated tablets Copalia HCT 5 mg/160 mg/25 mg film-coated tablets Copalia HCT 10 mg/160 mg/25 mg film-coated tablets Copalia HCT 10 mg/320 mg/25 mg film-coated tablets amlodipine/valsartan/hydrochlorothiazide
Croatian: Copalia HCT 5 mg/160 mg/12,5 mg filmom obložene tablete Copalia HCT 10 mg/160 mg/12,5 mg filmom obložene tablete Copalia HCT 5 mg/160 mg/25 mg filmom obložene tablete Copalia HCT 10 mg/160 mg/25 mg filmom obložene tablete Copalia HCT 10 mg/320 mg/25 mg filmom obložene tablete amlodipin/valsartan/hidroklorotiazid
English: Frequency Copalia HCT
Croatian: Učestalost Copalia HCT
English: How to store Copalia HCT
Croatian: Kako čuvati Copalia HCT
English: Grapefruit and grapefruit juice should not be consumed by people who are prescribed Copalia HCT.
Croatian: Bolesnici kojima je propisan Copalia HCT ne smiju konzumirati grejp ili sok od grejpa.
English: Copalia HCT 10 mg/320 mg/25 mg film-coated tablets
Croatian: Copalia HCT 10 mg/320 mg/25 mg filmom obložene tablete
English: What Copalia HCT looks like and contents of the pack Copalia HCT 5 mg/160 mg/12.5 mg film-coated tablets are white, oval tablets with “NVR” on one side and “VCL” on the other side.
Croatian: Kako Copalia HCT izgleda i sadržaj pakiranja Copalia HCT 5 mg/160 mg/12,5 mg filmom obložene tablete su bijele, ovalne tablete s oznakom „NVR“ na jednoj strani i „VCL“ na drugoj strani.
English: There is limited experience with the use of Copalia HCT, particulary at the maximum dose, in patients with heart failure and coronary artery disease.
Croatian: U bolesnika sa zatajenjem srca i bolešću koronarnih arterija postoji ograničeno iskustvo s primjenom Copalia HCT-a, posebno u najvišoj dozi.
English: Copalia HCT should be discontinued if hypercalcaemia develops during treatment.
Croatian: Ako se tijekom liječenja Copalia HCT-om razvije hiperkalcijemija, liječenje treba prekinuti.
English: if you experience dizziness and/or fainting during treatment with Copalia HCT, tell your doctor as soon as possible.
Croatian: Nemojte više nikad uzimati Copalia HCT. ako tijekom liječenja Copalia HCT-om osjetite omaglicu i/ili nesvjesticu, o tome što prije obavijestite svoga liječnika.
English: EU/1/09/575/043 280 film-coated tablets
Croatian: EU/1/09/575/043 280 filmom obloženih tableta
English: Copalia HCT 5 mg/160 mg/12.5 mg film-coated tablets
Croatian: Copalia HCT 5 mg/160 mg/12,5 mg filmom obložene tablete
English: Copalia HCT 10 mg/160 mg/25 mg film-coated tablets
Croatian: Copalia HCT 10 mg/160 mg/25 mg filmom obložene tablete
English: EU/1/09/575/004 56 film-coated tablets
Croatian: EU/1/09/575/004 56 filmom obloženih tableta
English: Copalia HCT 5 mg/160 mg/25 mg film-coated tablets
Croatian: Copalia HCT 5 mg/160 mg/25 mg filmom obložene tablete
English: Copalia HCT 10 mg/160 mg/12.5 mg film-coated tablets
Croatian: Copalia HCT 10 mg/160 mg/12,5 mg filmom obložene tablete
English: EU/1/09/575/042 98 film-coated tablets
Croatian: EU/1/09/575/042 98 filmom obloženih tableta
English: Copalia HCT 10 mg/160 mg/12.5 mg film-coated tablets are pale yellow, oval tablets with “NVR” on one side and “VDL” on the other side.
Croatian: Copalia HCT 10 mg/160 mg/12,5 mg filmom obložene tablete su blijedo žute, ovalne tablete s oznakom „NVR“ na jednoj strani i „VDL“ na drugoj strani.
English: Copalia HCT 10 mg/320 mg/25 mg film-coated tablets are brown-yellow, oval tablets with “NVR” on one side and “VFL” on the other side.
Croatian: Copalia HCT 10 mg/320 mg/25 mg filmom obložene tablete su žuto-smeđe, ovalne tablete s oznakom „NVR“ na jednoj strani i „VFL“ na drugoj strani.
English: EU/1/09/575/031 280 film-coated tablets
Croatian: EU/1/09/575/031 280 filmom obloženih tableta
English: EU/1/09/575/007 280 film-coated tablets
Croatian: EU/1/09/575/007 280 filmom obloženih tableta
English: EU/1/09/575/041 90 film-coated tablets
Croatian: EU/1/09/575/041 90 filmom obloženih tableta
English: EU/1/09/575/006 98 film-coated tablets
Croatian: EU/1/09/575/006 98 filmom obloženih tableta
English: Copalia HCT 5 mg/160 mg/25 mg film-coated tablets are yellow, oval tablets with “NVR” on one side and “VEL” on the other side.
Croatian: Copalia HCT 5 mg/160 mg/25 mg filmom obložene tablete su žute, ovalne tablete s oznakom „NVR“ na jednoj strani i „VEL“ na drugoj strani.
English: Copalia HCT 10 mg/320 mg/25 mg film-coated tablets amlodipine/valsartan/hydrochlorothiaziade
Croatian: Copalia HCT 10 mg/320 mg/25 mg filmom obložene tablete amlodipin/valsartan/hidroklorotiazid
English: EU/1/09/575/016 56 film-coated tablets
Croatian: EU/1/09/575/016 56 filmom obloženih tableta
English: EU/1/09/575/054 98 film-coated tablets
Croatian: EU/1/09/575/054 98 filmom obloženih tableta
English: EU/1/09/575/018 98 film-coated tablets
Croatian: EU/1/09/575/018 98 filmom obloženih tableta
English: EU/1/09/575/040 56 film-coated tablets
Croatian: EU/1/09/575/040 56 filmom obloženih tableta